Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM6B | O15054 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.60 |
| ▸ | RECQL | P46063 | 5/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.60 |
| ▸ | USP2 | O75604 | 3/20 | 0.60 |
| ▸ | LCK | P06239 | 3/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | HTR2A | P28223 | 2/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.60 |
| ▸ | FYN | P06241 | 2/20 | 0.60 |
| ▸ | EGFR | P00533 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | MME | P08473 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5063603 | 1.00 | KDM6B (0.62) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL30724831 | 0.88 | KDM6B (0.64) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| Levodopa SCHEMBL4551885 | 0.86 | SLC7A5 (0.69) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL29669984 | 0.86 | KDM6B (0.62) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL1828829 | 0.85 | ESR1 (0.49) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL1828830 | 0.85 | ESR1 (0.49) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL2283369 | 0.85 | KDM6B (0.60) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL3736877 | 0.85 | KDM6B (0.60) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL32662363 | 0.85 | KDM6B (0.60) | KDM6BKDM4EHSD17B10TDP1RECQL | |
| SCHEMBL18800390 | 0.85 | KDM6B (0.60) | KDM6BKDM4EHSD17B10TDP1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127167-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-04-24 | — | — | US | claimed |
| CN-119752091-A | ABS composite material containing halogen-free flame retardant and preparation process thereof | 东莞市宇捷实业投资有限公司 | 2025-04-04 | — | — | CN | claimed |
| EP-4401555-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2024-07-24 | — | — | EP | claimed |
| CN-117820374-A | DOPO-based Schiff base derivative halogen-free flame retardant, and preparation method and application thereof | 浙江理工大学 | 2024-04-05 | — | — | CN | claimed |
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | claimed |
| US-12397060-B2 | pHLIP®-mediated intracellular delivery of immuno-stimulatory compounds | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2025-08-26 | — | — | US | disclosed |
| CN-119752091-B | ABS composite material containing halogen-free flame retardant and preparation process thereof | 东莞市宇捷实业投资有限公司 | 2025-07-15 | — | — | CN | disclosed |
| US-12290575-B2 | Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2025-05-06 | — | — | US | disclosed |
| US-20250127167-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-04-24 | — | — | US | disclosed |
| CN-119752091-A | ABS composite material containing halogen-free flame retardant and preparation process thereof | 东莞市宇捷实业投资有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119752091-A | ABS composite material containing halogen-free flame retardant and preparation process thereof | 东莞市宇捷实业投资有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-114965764-B | Diagnosis and treatment of constipation | 陕西安宁云生生物技术有限公司 | 2024-12-31 | — | — | CN | disclosed |
| US-11738096-B2 | Method of detecting diseased or damaged tissue with a pH-triggered polypeptide fluorophore composition | YALE UNIVERSITY (US) | 2023-08-29 | — | — | US | disclosed |
| US-11723897-B2 | Fatty acids as anti-inflammatory agents | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2023-08-15 | — | — | US | disclosed |
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | disclosed |
| WO-2022229951-A1 | ANTIMICROBIAL AGENTS AND FILMS MADE THEREFROM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022224247-A1 | ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-10-27 | — | — | WO | disclosed |
| CN-114965764-A | Diagnosis and treatment of constipation | 陕西安宁云生生物技术有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-20220088208-A1 | PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2022-03-24 | — | — | US | disclosed |
| US-11267853-B2 | Carbohydrate tethering at cell surfaces to induce immune response | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2022-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11738096-B2 | Method of detecting diseased or damaged tissue with a pH-triggered polypeptide fluorophore composition | VIP, FUCA1, FGB | KDM6B 4504/4885KDM4E 4881/4885HSD17B10 3315/4885 |
| US-11267853-B2 | Carbohydrate tethering at cell surfaces to induce immune response | CD4, CD14, CD69 | KDM6B 2650/4885KDM4E 3472/4885HSD17B10 2629/4885 |
| US-20220088208-A1 | PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS | STING1, MAVS, IRF3 | KDM6B 3299/4885KDM4E 3697/4885HSD17B10 4472/4885 |
| US-12397060-B2 | pHLIP®-mediated intracellular delivery of immuno-stimulatory compounds | STING1, MAVS, IRF3 | KDM6B 3299/4885KDM4E 3697/4885HSD17B10 4472/4885 |
| US-12290575-B2 | Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide | NPPA, LNPEP, VIP | KDM6B 4491/4885KDM4E 4877/4885HSD17B10 3261/4885 |
| US-11723897-B2 | Fatty acids as anti-inflammatory agents | ALOX15B, FFAR1, ALOX12 | KDM6B 2503/4885KDM4E 2120/4885HSD17B10 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.